Excellence in Pharmaceutical Contracting & Pricing

Industries Profiled:
Pharmaceutical; Biotech; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care


Companies Profiled:
Abbott Laboratories; Amgen; Baxter Healthcare; Bayer; Boehringer-Ingelheim; Genzyme; Johnson & Johnson Healthcare Systems; Pfizer; Philips Medical Systems; Roche

Study Snapshot

In today’s fast changing, complex market, competitive contracting and pricing presents tremendous opportunities and challenges for pharmaceutical and medical device companies. While fast and accurate pricing and payment excellence create a pathway to profitable growth, many pricing organizations labor to deliver expected results and demonstrate value. This study takes a fresh look at how best-in-class companies:

1. Structure and organize their contracting functions to optimize their service: cost, quality and value
2. Manage risk
3. Communicate value and receive recognition for services rendered

• Pinpointing their contracting and pricing organization’s key strengths and improvement areas relative to high-performing companies 
• Aligning organizational structure and resources for maximizing operational efficiency and effectiveness 
• Creating a roadmap for building high-impact contracting capabilities to drive business value 

• High performing contracting organizations focus on corporate growth in their management processes, objectives and internal communications.
• Automation, standardizations and early warning systems are key contracting value fronts by which to manage speed, cost and quality in an increasingly complex and high-volume contracting environment.
• Customize upward communications to demonstrate value to internal customers.